CDK5 and hepatocellular carcinoma: Recent studies found that CDK5-mediated phosphorylation of TPX2 (Target protein for Xklp2) at Ser486 stabilizes TPX2 to promote the migration of hepatocellular carcinoma cells [69] (Fig. 3b).